RESUMO
BACKGROUND: Melanonychia may be the presenting sign of ungual melanoma. However, there are insufficient basic clinical data for melanonychia in Korean patients. OBJECTIVE: We sought to identify basic clinical data and devise a classification algorithm for melanonychia. METHODS: In all, 275 patients with melanonychia who visited our clinic from January 2002 to August 2014 were included in this study. We reviewed medical records, clinical and dermoscopic photographs, and histopathologic findings and we assessed demographics (eg, age); medical (eg, systemic diseases), family, and trauma (eg, nail biting) history; and physical findings (eg, affected number and site). RESULTS: The 5 most common causes of melanonychia in Korean patients were subungual hemorrhage (29.1%), nail matrix nevus (21.8%), trauma-induced pigmentation (14.5%), nail apparatus lentigo (11.6%), and ethnic-type nail pigmentation (8.0%). Melanoma was diagnosed in 6.2% of patients. Ethnic-type nail pigmentation was commonly identified. LIMITATIONS: This is a retrospective study from a single center. CONCLUSION: We propose a revised diagnostic algorithm for melanonychia to assist in the evaluation of this condition.
Assuntos
Hemorragia/complicações , Melanoma/diagnóstico , Doenças da Unha/diagnóstico , Doenças da Unha/etiologia , Nevo Pigmentado/diagnóstico , Neoplasias Cutâneas/diagnóstico , Adulto , Idoso , Algoritmos , Dermoscopia , Diagnóstico Diferencial , Feminino , Traumatismos dos Dedos/complicações , Humanos , Lentigo/diagnóstico , Masculino , Melanoma/patologia , Pessoa de Meia-Idade , Doenças da Unha/patologia , Onicomicose/diagnóstico , República da Coreia , Estudos Retrospectivos , Neoplasias Cutâneas/patologia , Pigmentação da Pele , Adulto JovemRESUMO
BACKGROUND: Conventional treatments for warts like cryotherapy are limited by the pain during procedures, especially in pediatric patients. Imiquimod is a topical immune response modifier, but the thick stratum corneum of common warts prevents drug permeation through skin. OBJECTIVE: To evaluate the efficacy and safety of fractional laser/topical 5% imiquimod cream for the treatment of warts in children. METHODS: Eleven pediatric patients with multiple recalcitrant common warts were included. Lesions were treated using an ablative fractional 2,940-nm Er:YAG laser at 1- or 2-week interval. After each laser treatment session, imiquimod 5% cream was self-applied once daily 5 days a week. Response and adverse effects were assessed 2 weekly until complete clearance or up to maximum of 48 weeks. Pain during fractional laser was assessed using a visual analogue scale (0-10). RESULTS: Eight of the 11 (72.7%) children experienced complete clearance. Mean duration was 29.7 (16-48) weeks, and the mean number of fractional laser was 17.5 (8-37). No significant adverse effect was observed. Pain visual analogue scale during fractional laser was 2.4 (1-4) compared to 6.2 (5-8) during cryotherapy. CONCLUSION: This pilot study indicates that fractional laser-assisted topical imiquimod may provide benefit for recalcitrant warts in children.
Assuntos
Aminoquinolinas/uso terapêutico , Indutores de Interferon/uso terapêutico , Lasers de Estado Sólido/uso terapêutico , Verrugas/tratamento farmacológico , Administração Tópica , Adolescente , Aminoquinolinas/administração & dosagem , Anestesia Local/métodos , Criança , Feminino , Humanos , Imiquimode , Indutores de Interferon/administração & dosagem , Masculino , Medição da Dor , Projetos Piloto , Resultado do TratamentoRESUMO
BACKGROUND: Some patients with pigmented basal cell carcinoma (pBCC) had a history of laser ablation after misdiagnosis, which may conceal the dermoscopic clues of malignancy. OBJECTIVE: The objective of this study was to investigate the question of whether the classic and nonclassic dermoscopic patterns of BCCs may be concealed by past laser ablation. METHODS: Classic and nonclassic dermoscopic patterns were examined in 55 pBCC patients with a history of laser ablation and another 150 control pBCC patients. RESULTS: All but 4 of the study patients (92.3%) showed at least 1 classic pattern of BCC, whereas every control patient showed more than 1 classic pattern (p = .995). Compared with the control group, the detection rate of large blue/gray ovoid nests, multiple blue/gray globules, and ulceration was found to be significantly decreased in the study group (p < .05). However, 4 patients who lacked classic patterns showed at least 1 nonclassic pattern. CONCLUSION: Previous laser ablation in pBCC may conceal the classic dermoscopic patterns by reducing the detection rate. Therefore, more prudent and detailed dermoscopic monitoring is required in suspected cases of pBCC, especially in patients with a history of laser ablation.
Assuntos
Carcinoma Basocelular/patologia , Carcinoma Basocelular/cirurgia , Dermoscopia , Terapia a Laser , Neoplasias Cutâneas/patologia , Neoplasias Cutâneas/cirurgia , Idoso , Idoso de 80 Anos ou mais , Estudos de Casos e Controles , Cor , Feminino , Humanos , Masculino , Microvasos/patologia , Pessoa de Meia-Idade , Úlcera Cutânea/patologiaRESUMO
The effectiveness of intermittent topical tacrolimus to prevent relapse in patients with stabilized facial seborrhoeic dermatitis has not been evaluated. The aim of this study was to determine whether proactive use of 0.1% tacrolimus ointment can keep adult facial seborrhoeic dermatitis in remission. A total of 75 patients who had stabilized facial seborrhoeic dermatitis after 2 weeks' (open-label induction) treatment with 0.1% tacrolimus were randomized in a double-blind fashion to treatment with 0.1% tacrolimus once a week, twice a week, or vehicle twice a week, for 10 weeks (maintenance). Significant improvement in erythema, scaling and pruritus compared with baseline was maintained during the maintenance phase in both tacrolimus groups, but not in the vehicle group. The mean recurrence rate according to global assessment was significantly higher in the tacrolimus once-weekly group than in the twice-weekly group. In conclusion, twice-weekly treatment with 0.1% tacrolimus ointment had superior effects in keeping facial seborrhoeic dermatitis in remission.
Assuntos
Dermatite Seborreica/tratamento farmacológico , Fármacos Dermatológicos/administração & dosagem , Dermatoses Faciais/tratamento farmacológico , Tacrolimo/administração & dosagem , Administração Cutânea , Adulto , Idoso , Distribuição de Qui-Quadrado , Dermatite Seborreica/diagnóstico , Fármacos Dermatológicos/efeitos adversos , Método Duplo-Cego , Esquema de Medicação , Dermatoses Faciais/diagnóstico , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Pomadas , Indução de Remissão , República da Coreia , Prevenção Secundária , Tacrolimo/efeitos adversos , Fatores de Tempo , Resultado do TratamentoRESUMO
Tinea incognito (TI) is a dermatophytic infection which has lost its typical clinical appearance because of improper use of steroids or calcineurin inhibitors. The incidence of TI is increasing nowadays. We conducted retrospective review on 283 patients with TI from 25 dermatology training hospitals in Korea from 2002-2010 to investigate the demographical, clinical, and mycological characteristics of TI, and to determine the associated risk factors. More than half (59.3%) patients were previously treated by non-dermatologists or self-treated. The mean duration of TI was 15.0 ± 25.3 months. The most common clinical manifestations were eczema-like lesion, psoriasis-like, and lupus erythematosus-like lesion. The trunk and face were frequently involved, and 91 patients (32.2%) also had coexisting fungal infections. Among 67 isolated strains, Trichophyton rubrum was the most frequently detected (73.1%). This is the largest study of TI reported to date and the first investigational report concerning TI in Korea. We suggest that doctors should consider TI when a patient has intractable eczema-like lesions accompanied by tinea pedis/unguium. Furthermore, there should be a policy change, which would make over-the-counter high-potency topical steroids less accessible in some countries, including Korea.
Assuntos
Tinha/diagnóstico , Adolescente , Adulto , Idoso , Idoso de 80 Anos ou mais , Criança , Pré-Escolar , Demografia , Eczema/patologia , Face/patologia , Feminino , Humanos , Lúpus Eritematoso Cutâneo/patologia , Masculino , Pessoa de Meia-Idade , Psoríase/patologia , República da Coreia , Estudos Retrospectivos , Fatores de Risco , Tinha/microbiologia , Trichophyton/isolamento & purificação , Adulto JovemRESUMO
This systematic review was conducted to examine the value of the preoperative history and physical (H&P) examination and preoperative care prior to cataract extraction and the resulting outcomes of adverse events, patient experience, and cost. Four databases were searched using appropriate keywords from 2012 to 2022. Observational studies, randomized controlled trials, and quality improvement studies with data on the precataract H&P were included. Outcome measures were adverse events, cost, and patient experience. Of the 4,170 studies screened, 12 studies were included. Risk stratification of patients into a high-risk group with an H&P and a low-risk group without an H&P resulted in an increased incidence of minor adverse events in the low-risk group but did not increase the incidence of major adverse events or surgical adverse events. A short-term cost savings was reported, and patient experience was unchanged. In 2020, the Centers for Medicare and Medicaid Services removed the requirement for the precataract H&P within 30 days prior to ambulatory surgery, which has implications for surgery center policy. More research on the role of the preoperative H&P on patient experience, adverse events, cost, and outcomes should be conducted, given the methodological heterogeneity of this review.
Assuntos
Extração de Catarata , Catarata , Idoso , Estados Unidos , Humanos , Medicare , Redução de Custos , Exame FísicoAssuntos
Artrite Psoriásica/tratamento farmacológico , Imunoglobulina G/efeitos adversos , Linfoma de Zona Marginal Tipo Células B/etiologia , Psoríase/tratamento farmacológico , Neoplasias da Glândula Tireoide/etiologia , Anti-Inflamatórios não Esteroides/uso terapêutico , Artrite Psoriásica/diagnóstico , Quimioterapia Adjuvante , Relação Dose-Resposta a Droga , Esquema de Medicação , Quimioterapia Combinada , Etanercepte , Feminino , Seguimentos , Humanos , Imunoglobulina G/uso terapêutico , Linfoma de Zona Marginal Tipo Células B/patologia , Linfoma de Zona Marginal Tipo Células B/terapia , Metotrexato/uso terapêutico , Pessoa de Meia-Idade , Psoríase/diagnóstico , Radioterapia Adjuvante , Doenças Raras , Receptores do Fator de Necrose Tumoral/uso terapêutico , Recidiva , Retratamento , Medição de Risco , Índice de Gravidade de Doença , Neoplasias da Glândula Tireoide/patologia , Neoplasias da Glândula Tireoide/terapia , Tireoidectomia/métodos , Recusa do Paciente ao TratamentoRESUMO
BACKGROUND: The glomus tumor, described as a painful subcutaneous nodule, commonly occurs in subungual regions and is accompanied by tenderness and temperature sensitivity. In treatment of subungual glomus tumor, surgical excision is known to be the only curative method. Under surgical approach, it is challenging to minimize postoperative nail deformity and to reduce tumor recurrence. OBJECTIVE: To evaluate the efficacy and safety of surgical treatment of subungual glomus tumor using simple blunt dissection. MATERIALS AND METHODS: Twenty-three patients diagnosed with subungual glomus tumor underwent surgical procedure using a dorsal transungual approach. A single linear incision was made above the tumor, and the exposed mass was meticulously dissected with the opposite end of a single-end probe, and the tumor "popped up." Recurrence of symptom, tumor recurrence, and local complication were evaluated through long-term follow-up. RESULTS: After a mean follow-up period of 30 months, only one case recurred, and partial-thickness skin necrosis occurred around the tourniquet site. There was no postoperative nail deformity. CONCLUSIONS: In treatment of subungual glomus tumor, meticulous simple blunt dissection using a transungual approach led the tumor to "pop up" from the tumor bed. This unique and simple method of treating subungual glomus tumor showed low recurrence and minimal complications.
Assuntos
Tumor Glômico/cirurgia , Doenças da Unha/cirurgia , Neoplasias Cutâneas/cirurgia , Adulto , Idoso , Diagnóstico Diferencial , Feminino , Seguimentos , Tumor Glômico/patologia , Humanos , Imageamento por Ressonância Magnética , Masculino , Pessoa de Meia-Idade , Doenças da Unha/patologia , Neoplasias Cutâneas/patologiaAssuntos
Anti-Inflamatórios/uso terapêutico , Betametasona/análogos & derivados , Calcitriol/análogos & derivados , Fármacos Dermatológicos/uso terapêutico , Onicólise/tratamento farmacológico , Adolescente , Adulto , Idoso , Anti-Inflamatórios/efeitos adversos , Betametasona/efeitos adversos , Betametasona/uso terapêutico , Calcitriol/efeitos adversos , Calcitriol/uso terapêutico , Criança , Pré-Escolar , Fármacos Dermatológicos/efeitos adversos , Combinação de Medicamentos , Feminino , Dermatoses do Pé/tratamento farmacológico , Dermatoses da Mão/tratamento farmacológico , Humanos , Masculino , Pessoa de Meia-Idade , Pomadas , Índice de Gravidade de Doença , Adulto JovemAssuntos
Acne Vulgar/tratamento farmacológico , Peróxido de Benzoíla/uso terapêutico , Fármacos Dermatológicos/uso terapêutico , Ceratolíticos/uso terapêutico , Naftalenos/uso terapêutico , Acne Vulgar/patologia , Adapaleno , Administração Tópica , Adulto , Povo Asiático , Peróxido de Benzoíla/efeitos adversos , Fármacos Dermatológicos/administração & dosagem , Fármacos Dermatológicos/efeitos adversos , Combinação de Medicamentos , Face , Feminino , Humanos , Irritantes , Ceratolíticos/efeitos adversos , Masculino , Naftalenos/administração & dosagem , Naftalenos/efeitos adversos , Cooperação do Paciente , Pele/patologia , Adulto JovemRESUMO
Rosacea is a common chronic inflammatory skin condition. Although several epidemiological and etiologic studies with large sample sizes have been conducted on Caucasians, such data regarding Asian populations are lacking. A total of 580 patients diagnosed with rosacea were enrolled from October 2014 to February 2015 at 14 general hospitals. Questionnaires, including the standard classification and grading system, were used for evaluation. The average age of the patients was 47.9 years. While 83.8% of patients revealed a single subtype, 16.2% of patients revealed mixed subtypes showing two or more subtypes simultaneously. Erythematotelangiectatic rosacea (ETR) was the most prevalent subtype. ETR combined with papulopustular rosacea showed the highest proportion in the mixed subtype group. Mild severity was revealed in 71.9% of patients. The most common aggravating factor was emotional changes (51.7%), followed by stress (48.4%). Approximately half of the patients (47.4%) showed relatively low awareness of rosacea. By identifying the epidemiological and etiologic features in Korea, we can suggest valuable clinical avenues for research, education and awareness among rosacea patients.
Assuntos
Conhecimentos, Atitudes e Prática em Saúde , Rosácea/epidemiologia , Adolescente , Adulto , Idoso , Criança , Estudos Transversais , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Educação de Pacientes como Assunto , Prevalência , República da Coreia/epidemiologia , Rosácea/patologia , Índice de Gravidade de Doença , Pele/patologia , Inquéritos e Questionários , Adulto JovemAssuntos
Fármacos Dermatológicos/administração & dosagem , Di-Hidroxicolecalciferóis/administração & dosagem , Dermatoses Faciais/tratamento farmacológico , Melanose/tratamento farmacológico , Administração Tópica , Adolescente , Criança , Feminino , Humanos , Masculino , Pomadas/administração & dosagem , Resultado do Tratamento , Adulto JovemRESUMO
BACKGROUND: Sublingual immunotherapy (SLIT) with house dust mites (HDM) preparation has recently been proven to be beneficial for treating allergic rhinitis and asthma. However, there has been no report regarding the efficacy and safety of SLIT in Korean patients with atopic dermatitis (AD). OBJECTIVE: We intended to investigate the efficacy and safety of SLIT in Korean patients with AD. METHODS: A total of 34 patients with AD and immunoglobulin E (IgE)-proven HDM sensitization (Class ≥3) were recruited. Eczema area and severity index (EASI) score, total serum IgE level, specific IgE assays to Dermatophagoides pteronyssinus, D. farinae, and adverse effects were recorded during follow-up. "Responder" was defined as a patient with ≥30% improvement in EASI score after SLIT. RESULTS: Twenty-three patients continued SLIT for 12 months or more, whereas 3 patients (8.8%) dropped out because of exacerbation of dermatitis, and 8 patients (23.5%) were lost to follow-up. The average duration of SLIT treatment was 22.4 months (range, 12~32 months). EASI scores reduced significantly after 6 months of treatment (p<0.05) compared with those at baseline. A total of 18 patients were determined to be responders to SLIT after 6 months. Total and specific IgE serum levels did not significantly reduce after SLIT. No patients experienced serious adverse events, with the exception of two patients who developed transient lip and tongue swelling. CONCLUSION: Our study demonstrated that SLIT with HDM extracts is effective and tolerable in Korean patients with AD. Further controlled long-term trials are required to reinforce the current results.
RESUMO
Along with increasing public concerns on acne and its complications, increasing treatment options seem to lead more acne patients to clinics globally, including Korea. The aim of the present study was to investigate the number and distribution of acne patients according to age group by analyzing number and age of outpatients from several general hospitals in Korea. Two retrospective multicenter studies including 14 general hospitals for a maximum of 10 years were conducted by medical chart review of acne patients. During the last 10 years, total acne patients have increased by 60% in number and patients under the age of 19 years have doubled. Adult acne patients (aged >18 years) accounted for the biggest portion in total acne patients at over 80%. Although upper grade of elementary school patients (aged 10-12 years) accounted for the biggest portion among the childhood acne patients, children under 10 years have also increased rapidly by 73% during the last 10 years. Childhood acne patients (aged <13 years) accounted for 11% of total acne patients. We found that acne patients were increasing consistently and the portion of those aged under 19 years is getting bigger. Additionally, childhood acne patients have increased remarkably.
Assuntos
Acne Vulgar/epidemiologia , Adolescente , Adulto , Fatores Etários , Criança , Pré-Escolar , Feminino , Humanos , Lactente , Masculino , República da Coreia/epidemiologia , Estudos Retrospectivos , Adulto JovemRESUMO
BACKGROUND: Acupuncture is one of the most popular modalities used to treat various diseases in traditional Korean and Oriental medicine. However, its risk of adverse events can be easily overlooked. OBJECTIVE: We investigated dermatological adverse events associated with acupuncture to draw attention to the risk of such adverse events. METHODS: We evaluated the types of acupuncture, clinicopathologic diagnoses, treatments, and prognoses in patients with a causal relationship between acupuncture and dermatoses. RESULTS: The study population comprised 25 patients (mean age, 52 years) with a history of acupuncture. Bee venom acupuncture was performed the most frequently (13 of 25 patients), and most patients received acupuncture to control pain (19 of 25 patients). The most common adverse event was infectious skin disease such as atypical mycobacterial infection or pyoderma/abscess, followed by hypersensitivity reactions, localized lipoatrophy, and hypertrophic scar. Acupuncture-related dermatoses required a relatively long treatment period (average, 8.6 weeks). CONCLUSION: Various dermatoses may occur following acupuncture. To minimize the risk of these dermatoses, proper training and medical knowledge in acupuncture practice are necessary for medical personnel. Dermatologists, oriental medical practitioners, and patients should pay attention to the potential adverse events of acupuncture.
Assuntos
Terapia por Acupuntura/efeitos adversos , Dermatopatias/etiologia , Gordura Subcutânea/patologia , Adolescente , Adulto , Idoso , Atrofia/etiologia , Venenos de Abelha/efeitos adversos , Cicatriz Hipertrófica/etiologia , Dermatite Alérgica de Contato/etiologia , Humanos , Pessoa de Meia-Idade , Manejo da Dor/métodos , Estudos Retrospectivos , Dermatopatias/terapia , Dermatopatias Infecciosas/etiologia , Adulto JovemRESUMO
BACKGROUND: A variety of infectious, inflammatory, and neoplastic dermatoses can develop on the glans penis, and definitive diagnosis in such cases may be difficult owing to their non-specific symptoms and clinical appearance. Furthermore, data on dermatoses of the glans penis in Korea are limited. OBJECTIVE: In the present study, we aimed to determine the prevalence of dermatoses of the glans penis in Korea and provide clinical data to assist in making an accurate diagnosis. METHODS: We retrospectively reviewed the medical records, clinical photographs, and histologic slides of 65 patients with dermatoses of the glans penis that visited the Pusan National University Hospital between January 2004 and August 2013. RESULTS: Twenty-six types of dermatoses were identified: inflammatory dermatosis was the most common (38/65, 58.5%), followed by infectious (13/65, 20.0%), neoplastic (10/65, 15.4%), and other dermatoses (4/65, 6.2%). The most common dermatosis of the glans penis was seborrheic dermatitis, followed by lichen planus, herpes progenitalis, condyloma accuminatum, erythroplasia of Queyrat, Zoon's balanitis, and psoriasis. In the topographic analysis, the most common type of dermatosis was dermatoses that localized to the glans penis (39/65, 60.0%), followed by dermatoses involving the extra-genitalia and glans penis (22/65, 33.9%), and the genitalia (glans penis plus other genital areas) (4/65, 6.2%). CONCLUSION: This study shows the usefulness of a topographic approach in the diagnosis of dermatoses of the glans penis in Korea. The findings could be used as baseline data for establishing an accurate diagnosis in Koreans.
RESUMO
Purpose. To evaluate the efficacy of autologous tenon grafting combined with conjunctival flap as a treatment for scleromalacia or scleral thinning after pterygium excision without any additional donor graft tissue. Methods. Twenty-six cases underwent autologous advanced tenon grafting combined with sliding or rotating conjunctival flap for scleromalacia after pterygium surgery ranging from 2 years to 30 years. The extent of scleral defect measured from 2.0 mm to 6.8 mm in diameter. The cosmetic outcome was defined as complete resolution of scleromalacia or completely conjunctival reepithelialization and firm adhesion between subtenon and scleral tissue over scleral thinning without significant complications. Results. All cases achieved the covering of conjunctival and tenon or subtenon tissue over scleromalacia or scleral thinning with this procedure. Preoperative pain, inflammation, and choroidal exposure disappeared after surgery. Immediate postoperative complications, such as large wound dehiscence or reopening of the scleral wound, did not occur in any of the patients. There were no significant clinical complications during the mean postoperative follow-up period of 14.17 months in all cases. Conclusions. We obtained excellent outcome with fewer complications after autologous advanced tenon graft and conjunctival flap, without an additional donor graft, in scleromalacia or scleral thinning caused by previous pterygium excision.
RESUMO
BACKGROUND: Various therapeutic options, including surgery, electrocautery, cryotherapy, 5-fluorouracil treatment, laser therapy, radiotherapy, photodynamic therapy, and interferon-α/γ injection, have been employed to treat vulvar intraepithelial neoplasia (VIN) with varying degrees of success. To truly cure VIN, human papillomavirus elimination is considered important. OBJECTIVE: To investigate the efficacy of 5% imiquimod cream used to treat VIN in Korean patients. METHODS: We performed a prospective, uncontrolled, observational study. Nine patients with histologically confirmed VIN applied 5% imiquimod cream to their vulvar lesions three to five times a week until a clinical response was apparent. All lesions were photo-documented, and therapeutic efficacy was assessed in terms of local adverse effects lesion number, size, and hyperpigmentation. RESULTS: The mean treatment duration was 30.2 months, and the median follow-up period after therapy completion was 30 months. Of the nine patients recruited, six (66.6%) experienced complete responses (CR) or partial responses (PR). Hyperpigmented patches in the VIN lesions were evident in five subjects (55.6%), and all experienced either CR or PR. Only three patients (33.3%) suffered from local adverse effects, which were relieved after temporary suspension of therapy, and better outcomes were attained ultimately. CONCLUSION: The imiquimod cream was more efficacious when used to treat VIN of the hyperpigmented type compared with lesions lacking pigmentation. The unifocal nature of a lesion and the development of local adverse effects are useful factors when imiquimod cream is prescribed. However, although the cream is convenient and effective, regional resistance may develop, and close follow-up is essential because VIN may become malignant.